Is your child living with Congenital Hyperinsulinism?

A national clinical research study is currently enrolling babies diagnosed with Congenital Hyperinsulinism (HI).

About half of children with HI respond to standard medications, while others need additional treatment such as surgery. This study is testing the safety and effectiveness of a new investigational treatment for HI.


See if your child may qualify:

In order to qualify, the participant must: 

  • Be diagnosed with Congenital Hyperinsulinism
  • Be less than 12 months of age at screening

For more information on participating in this study, call (844) 311-3330.

Fix the following errors: